Arrowhead Pharmaceuticals, Inc.

549300O3CSB8T7OZ3D66

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: February 13, 2001

Address

Country: United States
Legal address: C/O PARACORP INCORPORATED, 2140 S DUPONT HWY19934 CAMDENUnited States (US-DE)
Head office: 177 East Colorado Boulevard, Suite 70091105 PasadenaUnited States (US-CA)

Identifier

LEI: 549300O3CSB8T7OZ3D66
Registered: March 30, 2016 at 01:58 AM UTC
Last updated: February 24, 2026 at 06:14 AM UTC
Next renewal: March 6, 2027 at 07:53 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 3354811
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 3354811
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300O3CSB8T7OZ3D66This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search